In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


VitaResc Biotech AG

Division of Curacyte AG

Latest From VitaResc Biotech AG

M&A Makes Sense for Procognia

Procognia's acquisition of fellow Apax portfolio company Sense Proteomic could indicate a more proactive stance from VCs intent on consolidating their bets behind likely winners.

BioPharmaceutical Europe

Evotec Goes Wholesale

VC firm Oxford Bioscience's deal with Evotec gives its portfolio companies discounted access to the German biotech's screening and chemistry services--but with no obligation.

Europe North America

Germany's Biotech Bust

Public markets around the world are down; Germany's Neuer Markt is also out. The demise of the exchange once hailed as Europe's most promising will hit more than just Germany's listed stocks. It affects the country's private sector, too, where young companies-and their investors-are frantically seeking ways to weather the storm.

BioPharmaceutical Europe

Dealmaking (07/02)

Summarizing the month in European dealmaking.

See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Inflammation
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Curacyte AG
  • Senior Management
  • Colin Bier, PhD, CEO
    Zoard Richter, VP, Fin.
    Werner Stuber, VP, R&D & Bus. Dev.
  • Contact Info
  • VitaResc Biotech AG
    Phone: (49) 89 85 65 28 50
    Fraunhofer Str. 17
    Martinsried, 82152